The Redox Podcast 43: Olive's journey to AI through robotic process automation (RPA)
Dec 07, 2021
Move fast, and automate things. That should be the unofficial mantra of Olive. With nearly $1 billion dollars in funding, they are a dynamo in health tech. In this episode of The Redox Podcast, Olive’s founder and CEO, Sean Lane, takes us on a ride from the visit to his hometown that sparked his hunger for healthcare innovation to the one idea that changed everything. Olive has a big vision for RPA in healthcare, and they plan to get there…fast.
Culture is a consequence; it’s a consequence of your actions. It is what you do every day. It is behaviors that you choose. It’s the decisions you make. That’s it. You don’’t prescribe it. It is a result.
Sean Lane, CEO of Olive
Key Moments
0:00 Sean’s history and the false starts that led him to Olive
9:40 What Sean thinks about growth and scaling the product organization
12:27 Olive’s framework for investing in research and development
13:26 How Olive tests and iterates on its business model… and cryptocurrency?
18:54 Having raised 3 rounds during the pandemic, Sean reveals Olive’s approach to fundraising
25:20 Olive’s philosophy on cultivating its internal culture
29:57 Sean shares his support system
32:23 How Olive decides on acquisitions
34:57 How a founder should think about being acquired
36:20 Why entrepreneurs should enter healthcare.